newsfilter
← Latest News
ACCESS Newswire·

Heat Biologics to Participate at M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference

Heat Biologics, Inc. (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, including multiple oncology product candidates and a novel COVID-19 vaccine, today announced that Jeff Wolf, CEO of Heat Biologics, has been invited to present at , hosted by M Vest LLC and Maxim Group LLC. The presentation will be available to all registered participants of the conference () on March 17th - 19th and will be posted on Heat Biologics' website () after March 19th.